The global interventional cardiology devices market size is expected to reach USD 26.84 Billion at a steady CAGR of 8.7% in 2028, according to latest analysis by Emergen Research. Steady growth of the interventional cardiology devices market can be attributed to rising incidence of cardiovascular diseases. Cardiovascular disease is the most common cause of death in the US, and is responsible for around 655,000 deaths every year. Coronary heart disease is the leading heart disease type that, in 2017, accounted for the deaths of 365,914 individuals in the US. Interventional cardiology devices deliver several benefits, including reduced chances of scar occurrence, reduced surgery complexity and time, and decreased pain. Additionally, rising incidence of cardiovascular diseases result in an increase in healthcare expenditure, which in turn, is driving revenue growth of the interventional cardiology devices market. According to the Centers for Disease Control and Prevention, heart attacks account for over USD 320.00 Billion in yearly healthcare expenditure and lost productivity, and this figure is expected to reach USD 818.00 Billion in 2030.
The Interventional Cardiology Devices Market report furthermore covers an inside examination of the vital contenders of the market alongside their development systems and business extension plans. In particular, the archive engages entrepreneurs to look for data about possible shoppers and where they can track down them. With a selective inclusion of the top sellers, the review empowers entrepreneurs to find out about the neighbourhood market and find expected shoppers.
The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Interventional Cardiology Devices market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.
The leading market contenders listed in the report are:
Abbott Laboratories, Terumo Corporation, iVascular, Boston Scientific Corporation, Edwards Lifesciences Corporation, B.Braun Melsungen, Medtronic PLC, Koninklijke Philips NV, Biosensors International Group Ltd., and Endocor GmbH
Emergen Research has segmented the global Interventional Cardiology Devices market on the basis of type, application, end-use, and region:
Segments Covered in this report are:
Product Type Outlook (Revenue, USD Billion; 20182028)
Angioplasty Stents
Angioplasty Balloons
Catheters
Structural Heart Devices
Plaque Modification Devices
Guidewires
Hemodynamic Flow Alteration Devices
Others
End-Use Outlook (Revenue, USD Billion; 20182028)
Hospitals
Ambulatory Surgical Centers
Others
Regional Outlook (Revenue, USD Billion; 20182028)
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Italy
Spain
BENELUX
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Israel
Rest of MEA
The various regions analyzed in the report include:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key Objectives of the Report:
Analysis and estimation of the Interventional Cardiology Devices Market size and share for the projected period of 2022-2030
Extensive analysis of the key players of the market by SWOT analysis and Porters Five Forces analysis to impart a clear understanding of the competitive landscape
Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Interventional Cardiology Devices Market
Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.